Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1, 25-dihydroxyvitamin D3, KH1060

Endocrinology

Volumn 136, Issue 3, 1995, Pages 866-872

  Mathieu, Chantal ^a   Waer, Mark ^a   Casteels, Kristina ^a   Laureys, Jos ^a   Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

20 EPI 22 OXA 24,26,27 TRIHOMOCALCITRIOL; LEXACALCITOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VITAMIN INTAKE;

ANIMAL; CALCITRIOL; CELL COUNT; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; HYPERCALCEMIA; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; PANCREATITIS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR;

EID: 0028847946     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.136.3.7867594     Document Type: Article

References (44)

1. Castano L, Eisenbarth GS 1990 Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679
2. Thai AC, Eisenbarth GS 1993 Natural history of IDDM. Diabetes Rev 1:1-14
3. Gepts W, Le Comte PM 1981 The pancreatic islets in diabetes. Am J Med 70:105-115
4. Weatherall D, Sarvetnick N, Shizuru JA 1992 Genetic control of diabetes mellitus. Diabetologia [Suppl 2] 35:1-7
5. Deschamps I, Beressi JP, Khalil I, Robert JJ, Hors J 1991 The role of genetic predisposition to type I (insulin-dependent) diabetes mellitus. Ann Med 23:427-435
6. Nepom GT 1993 Immunogenetics and IDDM. Diabetes Rev 1:93-103
7. Serreze DV 1993 Autoimmune diabetes results from genetic defects manifest by antigen presenting cells. FASEB J 7:1092-1096
8. Altmann DM, Sansom D, Marsh SGE 1991 What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 12:267-270
9. Langmuir PB, Bridgett MM, Bothwell AL, Crispe IN 1993 Bone marrow abnormalities in the non-obese diabetic mouse. Int Immunol 5:169-177
10. Serreze DV, Gaskins HR, Leiter EH 1993 Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543
11. Serreze DV, Leiter EH 1988 Defective activation of T suppressor cell function in nonobese diabetic mice. J Immunol 140:3801-3807
12. Mori Y, Suko M, Okudaira H, Matsuba I, Tsuruoka A, Sasaki A, Yokoyama H, Tanase T, Shida T, Nishumira M, Terada E, Ikeda Y 1986 Preventive effects of cyclosporine on diabetes in NOD mice. Diabetologia 29:244-247
13. Kai N, Motojima K, Tsunoda T, Kanematsu T 1993 Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. Transplantation 55:936-940
14. Baeder WL, Sredy J, Sehgal SN, Chang JY, Adams LM 1992 Ra-pamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol 89:174-178
15. Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B 1993 Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 150:2072-2080
16. Wilson K, Eisenbarth GS 1990 Immunopathogenesis and immunotherapy of type I diabetes. Annu Rev Med 41:497-502
17. Maclaren N, Lafferty K 1993 Perspectives in diabetes-the 12th International Immunology and Diabetes Workshop, Orlando, Florida. Diabetes 42:1099-1104
18. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R 1992 1, 25-Dihydroxy vitamin D3 prevents insulitis in NOD mice. Diabetes 41:1491-1495
19. 3. Diabetologia 37:552-558
20. Bikle DD 1992 Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev 13:765-784
21. Bouillon R, Allewaert K, Xiang DZ, Tan BK, Van Baelen H 1991 Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Bone Miner Res 6:1051-1057
22. Hewison M 1992 Vitamin D and the immune system. J Endocrinol 132:173-175
23. 3. J Cell Biochem 49:26-31
24. Saggese G, Federico G, Balestri M, Torriolo A 1989 Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest 12:329-335
25. 3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sei USA 84:3385-3391
26. 3. Clin Exp Immunol 94:412-417
27. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103-1107
28. 3 analogue 1, 25-dihydroxy-delta 16-cholecalciferol. Transplantation 54:762-763
29. Latini S, Binderup L 1991 KH1060 A new vitamin D analogue with potent effects on cell-mediated immune responses in vitro. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. Gene Regulation, Structure-Function Analysis and Clinical Application. De Gruyter Berlin, pp 516-519
30. Pozzilli P, Signore A, Williams AJ, Beales PE 1993 NOD mouse colonies around the world-recent facts and figures. Immunol Today 14:193-196
31. Verhaege J, Bouillon R, Lissens W, Visser WJ, Van Assche FA 1988 Diabetes and low Ca-P diet have opposite effects on adult and fetal bone mineral metabolism. Am J Physiol 254:E496-E504
32. Vanderschueren D, Jans I, Van Herck E, Moermans K, Verhaeghe J, Bouillon R 1994 Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. Bone Miner 26:123-131
33. 3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity and phagocytosis of human monocytes. Scand J Immunol 38:535-540
34. Zarrabeita MT, Riancho JA, Amado JA, Olmos JM, Gonzalez-Macias J 1992 Effect of calcitriol on the secretion of prostaglandin E2, IL-1 and tumor necrosis factor alpha by human monocytes. Bone 13:185-189
35. 3 on T lymphocyte subpopulations. Eur J Immunol 17:563-566
36. 3. Differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity 14:37-43
37. 3 inhibits the production of IL-12 by human monocytes and B cells. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D, A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. De Gruyter, Berlin, pp 531-539
38. Meehan MA, Kerman RH, Lemire JM 1992 1, 25-Dihydroxyvitamin D, enhances the generation of non specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol 140:400-409
39. Binderup L 1992 Immunological properties of vitamin D analogues and metabolites. Biochem Pharmacol 43:1885-1892
40. Dusso AS, Negrea L, Gunarwardhana S, Lopez-Hilker S, Finch J, Mori T, Nishii Y, Slatopolsky E, Brown AJ 1991 On the mechanism for the selective action of vitamin D analogs. Endocrinology 128: 1687-1692
41. 3 or its derivatives. J Biol Chem 269:2971-2981
42. 3 analogues with potent effects on cell growth regulation and immune responses: structure-activity studies. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. Gene Regulation, Structure-Function Analysis and Clinical Application. De Gruyter, Berlin, 478-485
43. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42:1569-1575
44. Veyron P, Pamphile R, Binderup L, Touraine L 1993 Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice. Transplant Immunol 1:72-76